Celyad Oncology Management
Management criteria checks 3/4
Celyad Oncology's CEO is Michel E. Lussier, appointed in Dec 2023, has a tenure of less than a year. total yearly compensation is €96.31K, comprised of 29.9% salary and 70.1% bonuses, including company stock and options. directly owns 0.35% of the company’s shares, worth €49.28K. The average tenure of the management team and the board of directors is 1.8 years and 7.3 years respectively.
Key information
Michel E. Lussier
Chief executive officer
€96.3k
Total compensation
CEO salary percentage | 29.9% |
CEO tenure | less than a year |
CEO ownership | 0.4% |
Management average tenure | 1.8yrs |
Board average tenure | 7.3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | €96k | €29k | -€8m |
Sep 30 2023 | n/a | n/a | -€20m |
Jun 30 2023 | n/a | n/a | -€31m |
Mar 31 2023 | n/a | n/a | -€35m |
Dec 31 2022 | €269k | €38k | -€41m |
Sep 30 2022 | n/a | n/a | -€32m |
Jun 30 2022 | n/a | n/a | -€26m |
Mar 31 2022 | n/a | n/a | -€25m |
Dec 31 2021 | €98k | n/a | -€27m |
Sep 30 2021 | n/a | n/a | -€17m |
Jun 30 2021 | n/a | n/a | -€15m |
Mar 31 2021 | n/a | n/a | -€18m |
Dec 31 2020 | €78k | n/a | -€17m |
Sep 30 2020 | n/a | n/a | -€28m |
Jun 30 2020 | n/a | n/a | -€29m |
Mar 31 2020 | n/a | n/a | -€29m |
Dec 31 2019 | €85k | n/a | -€29m |
Sep 30 2019 | n/a | n/a | -€32m |
Jun 30 2019 | n/a | n/a | -€35m |
Mar 31 2019 | n/a | n/a | -€36m |
Dec 31 2018 | €73k | n/a | -€37m |
Sep 30 2018 | n/a | n/a | -€49m |
Jun 30 2018 | n/a | n/a | -€60m |
Mar 31 2018 | n/a | n/a | -€58m |
Dec 31 2017 | €86k | n/a | -€56m |
Compensation vs Market: Michel E.'s total compensation ($USD102.29K) is below average for companies of similar size in the UK market ($USD343.58K).
Compensation vs Earnings: Michel E.'s compensation has been consistent with company performance over the past year.
CEO
Michel E. Lussier (67 yo)
less than a year
Tenure
€96,306
Compensation
Mr. Michel E. J. Lussier, MS, BME, MBA, has been Independent Director at Occlutech Holding AG since May 2021. He served as a Managing Director of Fjord Ventures LLC till October 2020. Mr. Lussier serves as...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | less than a year | €96.31k | 0.35% € 49.3k | |
Vice President of Finance & Administration | 1.8yrs | no data | no data | |
Communications & Investor Relations Director | no data | no data | no data | |
Head of Legal | 1.8yrs | no data | no data | |
Head of Intellectual Property | 1.8yrs | no data | no data | |
Head of R&D | 1.8yrs | no data | no data | |
Corporate Secretary | no data | no data | no data |
1.8yrs
Average Tenure
47.5yo
Average Age
Experienced Management: 0QFK's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | 17.3yrs | €96.31k | 0.35% € 49.3k | |
Independent Chairwoman of the Board | 7.3yrs | €101.10k | no data | |
Non-Executive Director | 16.3yrs | €15.50k | 0.14% € 19.1k | |
Member of Scientific Advisory Board | no data | €10.00k | no data | |
Member of Scientific Advisory Board | 8yrs | no data | no data | |
Member of Scientific Advisory Board | 8yrs | no data | no data | |
Independent Director | 3.9yrs | €49.50k | no data | |
Independent Director | 3.9yrs | €69.50k | no data | |
Non-Executive Director | 2.3yrs | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Non-Executive Director | 2.3yrs | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data |
7.3yrs
Average Tenure
65yo
Average Age
Experienced Board: 0QFK's board of directors are considered experienced (7.3 years average tenure).